Back

Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?

26 August 2017 (15:35 - 15:50)
Organised by:
Congress Presentation Part of: Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited) Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Ray Kausik

4 More presentations in this session

Presentation thumbnail
Introduction - Managing diabetes & CVD: is epigenetics a new way forward?
Professor L. Badimon (Barcelona, ES)
Presentation thumbnail
Promise of epigenetic modulation as a target in atherosclerotic patients.
Professor E. Stroes (Amsterdam, NL)
Presentation thumbnail
Insights from the first trials in epigenetics in human: what is the way forward?
Professor S. Nicholls (Melbourne, AU)
Presentation thumbnail
Discussion - Managing diabetes & CVD: is epigenetics a new way forward?
Professor R. Kausik

Access the full session

Session thumbnail
Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

The Event

Event poster

ESC Congress 2017

26 August 2017 15:35 CET
You may be interested in
thumbnail
Webinar
EAPC Webinar: Type 2 Diabetes and cardiovascular risk
12 March 2019
thumbnail
Congress Presentation
Novel multidisciplinary cardiometabolic clinic in a UK tertiary cardiology centre: early activity, interventions and potential for cardiovascular risk optimisation
27 August 2021
thumbnail
Webinar
How should I manage LEAD
5 February 2020
thumbnail
Congress Presentation
Lipid and secondary prevention 'up to date'
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources